A new finding claims that cancer can be treated with smallpox vaccine. A genetically engineered smallpox vaccine lessened the risk of death for patients with complex liver cancer by almost 60 percent in a mid-stage study, which prompts the launch of a later-stage trial. Scientists at institutions, which includes the University of California, San Diego, and privately held biotech company Jennerex Inc presented Phase 2 trial data Read more